Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
In a case–control cohort of 198 bipolar disorder patients and 107 controls from southern India, sequence analysis of all exons and flanking intronic regions of SYNGR1 identified a novel Lys99Glu missense variant in one patient and two common polymorphisms (Ser97Ser and an Asn insertion/deletion), with allelic associations observed for five SNPs (P = 0.028–0.00007) (PMID:16215643). No multi-family segregation data are available and the single occurrence of Lys99Glu limits variant-level evidence. A subsequent study in a Han Chinese bipolar cohort (n = 506) and 507 controls found no significant association for SYNGR1 polymorphisms (PMID:19665806), challenging reproducibility across populations. No functional assays specific to bipolar-related variants have been reported, although in silico predictions suggest potential impact on synaptic vesicle regulation. Together, these data constitute limited genetic support for SYNGR1 as a bipolar disorder susceptibility gene, requiring further replication in larger cohorts and mechanistic validation. Key take-home: SYNGR1 harbors preliminary association signals in bipolar disorder but lacks robust replication and functional confirmation, precluding current clinical diagnostic application.
Gene–Disease AssociationLimitedSingle case–control cohort of 198 bipolar disorder probands ([PMID:16215643]) with nominal SNP associations; no replication in an independent cohort Genetic EvidenceLimitedOne novel missense variant (Lys99Glu) in a single proband without segregation and modest case–control SNP associations Functional EvidenceLimitedNo bipolar disorder–specific functional assays reported; only in silico predictions available |